NEC ONCOIMMUNITY
Updated 55 days ago
Innovation Park, Ullernchausséen 64, 0379, Oslo, Norway
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. The AI technology can be used to identify optimal antigen/epitope targets for infectious disease vaccines, truly personalized cancer vaccines & T cell therapies in a clinically actionable timeframe, and also facilitate effective patient selection for cancer immunotherapy...
Company, science and technology vision of OncoImmunity.
Also known as: NEC OncoImmunity AS
Registration numbers: 913 062 616 (W)
Associated domains: immuneoprofiler.net, immuneoprofiler.org, immuneprofiler.com, immuneprofiler.org, immunescope.com, immunescope.org, immunoprofiler.com, immunoselect.com, insilicoavatar.com, insilicoavatar.net, insilicoavatar.org, nec-oncoimmunity.net, nec-oncoimmunity.org, neconcoimmunity.net, neconcoimmunity.org, neo-car.com, neo-car.org, neoantigenprofiler.com, neoantigenprofiler.org, neocar.org, neomunity.com, neomunity.org, neomutate.com, neomutate.org, novantigen.com, novantigen.org, onco-immunity.net, onco-immunity.org, onco-immunology.org, oncohla.com, oncohla.org, oncoimmunity.net, oncoimmunity.no, oncoimmunity.org, oncoimmunology.no, oncoimmunology.org, trojantigen.com, trojantigen.org